Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07303725 · ClinicalTrials.gov registry record
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
A clinical trial of Renal Cancer and Liver Cancer (Primary and Metastatic), sponsored by Palo Alto Veterans Institute for Research.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT07303725 is a study of Renal Cancer and Liver Cancer (Primary and Metastatic) that is actively recruiting participants, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 30 participants, below the 609-participant average among 29 other Renal Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07303725, a study of Renal Cancer and Liver Cancer (Primary and Metastatic), is actively recruiting participants, sponsored by Palo Alto Veterans Institute for Research.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to evaluate the feasibility, image quality, and procedural utility of a novel spectral CT technique using Canon Medical's 4D CT system during image-guided interventional oncology procedures
Conditions Studied
Study Locations (1)
California
- VA Palo Alto Healthcare System - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2026-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07303725
The ClinicalTrials.gov registry entry for NCT07303725 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 29 other Renal Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Palo Alto Veterans Institute for Research, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Renal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT07303725 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07303725 about?
NCT07303725 is a clinical study titled "Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology". This is a pilot study to evaluate the feasibility, image quality, and procedural utility of a novel spectral CT technique using Canon Medical's 4D CT system during image-guided interventional oncology procedures
What is the current status of trial NCT07303725?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-02-01. Estimated completion is 2026-09-01.
What conditions does trial NCT07303725 study?
This clinical trial studies the following conditions: Renal Cancer, Liver Cancer (Primary and Metastatic).
Who is sponsoring clinical trial NCT07303725?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07303725 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Kidney Cancer DNA Registry
RECRUITING
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RECRUITING
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
RECRUITING · Phase 1
-
Advanced Diffusion Imaging in Renal Cancer Patients
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.